About BioMonde
BioMonde is a company based in Gainesville (United States) founded in 2014.. BioMonde has raised $5.9 million across 1 funding round from investors including Oxford Capital and Development Bank of Wales. BioMonde offers products and services including BioBag and Larval Therapy. BioMonde operates in a competitive market with competitors including Tenaya Therapeutics, Orca Bio, Athira Pharma, Histogenics and Organogenesis, among others.
- Headquarter Gainesville, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biomonde Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.9 M (USD)
in 1 rounds
-
Latest Funding Round
$5.9 M (USD), Series A
Jun 02, 2014
-
Investors
Oxford Capital
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioMonde
BioMonde offers a comprehensive portfolio of products and services, including BioBag and Larval Therapy. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Net dressing containing larvae for effective wound debridement.
Natural treatment for rapid and selective wound bed preparation.
Funding Insights of BioMonde
BioMonde has successfully raised a total of $5.9M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.9 million completed in June 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $5.9M
-
First Round
First Round
(02 Jun 2014)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2014 | Amount | Series A - BioMonde | Valuation | Oxford Capital , Finance Wales |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioMonde
BioMonde has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Oxford Capital and Development Bank of Wales. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital is invested in UK technology sectors.
|
Founded Year | Domain | Location | |
|
Sustainable business finance is provided for companies in Wales.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioMonde
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioMonde
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biomonde Comparisons
Competitors of BioMonde
BioMonde operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tenaya Therapeutics, Orca Bio, Athira Pharma, Histogenics and Organogenesis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapeutics, including for Alzheimer’s and Parkinson’s, are developed.
|
|
| domain | founded_year | HQ Location |
Restorative cell therapies for orthopedic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Regenerative therapies for wound care are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Engineered cell and gene therapies are developed for multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about BioMonde
When was BioMonde founded?
BioMonde was founded in 2014.
Where is BioMonde located?
BioMonde is headquartered in Gainesville, United States.
Is BioMonde a funded company?
BioMonde is a funded company, having raised a total of $5.9M across 1 funding round to date. The company's 1st funding round was a Series A of $5.9M, raised on Jun 02, 2014.
What does BioMonde do?
BioMonde was founded in 2014 and is based in Gainesville, United States, within the medical devices sector. Larva therapy products, including the BioBag device, are produced using an aseptic process involving greenbottle fly larvae. These are supplied for debridement of wounds such as pressure ulcers, diabetic ulcers, venous stasis ulcers, and surgical or traumatic injuries. Operations occur in a specialized manufacturing facility.
Who are the top competitors of BioMonde?
BioMonde's top competitors include Tenaya Therapeutics, Athira Pharma and Orca Bio.
What products or services does BioMonde offer?
BioMonde offers BioBag and Larval Therapy.
Who are BioMonde's investors?
BioMonde has 2 investors. Key investors include Oxford Capital, and Development Bank of Wales.